venlafaxine

Generic: venlafaxine

Labeler: zydus pharmaceuticals usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine
Generic Name venlafaxine
Labeler zydus pharmaceuticals usa inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 150 mg/1

Manufacturer
Zydus Pharmaceuticals USA Inc.

Identifiers & Regulatory

Product NDC 70710-1350
Product ID 70710-1350_479c565e-3c2f-42a1-8a19-b7a210e5f28d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215622
Listing Expiration 2026-12-31
Marketing Start 2022-09-01

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707101350
Hyphenated Format 70710-1350

Supplemental Identifiers

RxCUI
808744 808748 808751 808753
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine (source: ndc)
Generic Name venlafaxine (source: ndc)
Application Number ANDA215622 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1350-1)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1350-3)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1350-9)
source: ndc

Packages (3)

70710-1350-1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1350-1) 70710-1350-3 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1350-3) 70710-1350-9 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1350-9)

Ingredients (1)

venlafaxine hydrochloride (150 mg/1)

Linked Drug Pages (1)

Venlafaxine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "479c565e-3c2f-42a1-8a19-b7a210e5f28d", "openfda": {"unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748", "808751", "808753"], "spl_set_id": ["db1d16b3-d1a2-4f41-adff-a87c17689aa0"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1350-1)", "package_ndc": "70710-1350-1", "marketing_start_date": "20220901"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1350-3)", "package_ndc": "70710-1350-3", "marketing_start_date": "20220901"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1350-9)", "package_ndc": "70710-1350-9", "marketing_start_date": "20220901"}], "brand_name": "Venlafaxine", "product_id": "70710-1350_479c565e-3c2f-42a1-8a19-b7a210e5f28d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "70710-1350", "generic_name": "Venlafaxine", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Venlafaxine", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA215622", "marketing_category": "ANDA", "marketing_start_date": "20220901", "listing_expiration_date": "20261231"}